Twist Bioscience Corp reports results for the quarter ended in June - Earnings Summary

Twist Bioscience

04/08/2023 14:32

* Twist Bioscience Corp  TWST.OQ  reported a quarterly
adjusted
loss of 78 cents​​ per share for the quarter ended in June. The
mean expectation of nine analysts for the quarter was for a loss
of $1.14 per share.
    * Revenue rose 13.6% to $63.74 million from a year ago;
analysts
expected $60.54 million. 
    * Twist Bioscience Corp's reported EPS for the quarter was a
loss
of $1.01​.
    * The mean earnings estimate of analysts had fallen by
about 0.7%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Twist Bioscience Corp shares had risen by 1.0% this
quarter and
lost 13.2% so far this year.
    * The company reported a quarterly loss of $57.4 million.
    * Wall Street's median 12-month price target for Twist
Bioscience
Corp is $22.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 2
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 4 at 01:32 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -1.14          -0.78          Beat
 Mar. 31 2023      -1.12          -1.04          Beat
 Dec. 31 2022      -1.13          -0.74          Beat
 Sep. 30 2022      -1.25          -0.91          Beat